News

iTeos Therapeutics: End To Belrestotug Program Leads To A Hold Rating
Teos Therapeutics downgraded to Hold after belrestotug failure and GSK deal ending. Read my updated analysis on ITOS stock ...
Biomednewsbreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering With Institutional Investor
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company focused on brain and central nervous system cancers, has priced a“reasonable best ef ...
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits
IDEXX Laboratories, Inc. reports strong Q1 FY25 growth with 4.7% organic revenue. Click for my updated look at IDXX stock ...